Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

Overview of attention for article published in Journal of Hematology & Oncology, April 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 59 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

DOSING REGIMEN

Application WO-2019081951-A1

World Intellectual Property Organisation (WIPO)

COMBINATORY CANCER TREATMENT

Application EP-2603222-A4

European Patent Office

COMBINATORY CANCER TREATMENT

Application EP-2603222-A1

European Patent Office

COMBINATION THERAPY USING RIBAVIRIN AS EIF4E INHIBITOR

Application WO-2013037043-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.